Latest & greatest articles for cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cancer

8561. Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS)

Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS) Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS) Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS) Lai M S, Yen M F, Kuo H S, Koong S L, Chen T H, Duffy S W Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The health technology investigated was breast cancer screening female relatives of breast -cancer index cases using mammography. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population

NHS Economic Evaluation Database.1998

8562. Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer

Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer Kaufman C S, Delbecq R, Jacobson L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Stereotactic core-needle biopsy (SCNB) was compared to wire-localised breast biopsy (WLBB) for the diagnosis of breast cancer in patients with mammography detected suspicious or highly suspicious lesions. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population The study population comprised

NHS Economic Evaluation Database.1998

8563. Colorectal cancer screening: efficiency and effectiveness

Colorectal cancer screening: efficiency and effectiveness Colorectal cancer screening: efficiency and effectiveness Colorectal cancer screening: efficiency and effectiveness Gyrd-Hansen D, Sogaard J, Kronborg O Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Using unhydrated Hemoccult (H-II) test for the colorectal cancer (CRC) screening of individuals between 45 and 75 years old every 2 years during a 10-year follow-up period. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Individuals between 45 and 75 years old. Setting Community and hospital. The economic study was carried out in Denmark. Dates to which data relate The main effectiveness data were collected between

NHS Economic Evaluation Database.1998

8564. Mammography screening as a method for the early detection of breast cancer

Mammography screening as a method for the early detection of breast cancer Mammography screening as a method for the early detection of breast cancer Mammography screening as a method for the early detection of breast cancer Gibis B, Busse R, Reese E, Richter K, Schwartz FW, Koebberling J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Gibis B, Busse R, Reese E, Richter K, Schwartz FW, Koebberling J. Mammography screening as a method for the early detection of breast cancer. German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA@ DIMDI). 1998 Authors' objectives This report aims to answer the following questions: - To what extent are reductions in the efficacy of a mammography screening programme with a participation rate of under 70% to be tolerated? - What quality

Health Technology Assessment (HTA) Database.1998

8565. Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease

Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer (...) and Alzheimer's disease Adams E, Flynn K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Adams E, Flynn K. Positron emission tomography: descriptive analysis of experience with PET in VA. A systematic review update of FDG-PET as a diagnostic test in cancer and Alzheimer's disease. Boston: VA Technology Assessment Program (VATAP). Technology Assessment

Health Technology Assessment (HTA) Database.1998

8566. Screening for ovarian cancer: a systematic review

Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review NHS Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHS Centre for Reviews and Dissemination. Screening for ovarian cancer: a systematic review (...) . University of York. CRD Report 13. 1998 Authors' objectives To provide an overview of the results of research evaluating screening for ovarian cancer. The specific objectives are: 1. To evaluate the performance of the current screening tests for ovarian cancer 2. To assess the adverse effects of screening, including morbidity associated with surgical intervention and the psychological morbidity associated with false positive diagnosis 3. To report on the stage of development of newer methods of screening

Health Technology Assessment (HTA) Database.1998

8567. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer

Systematic review of endoscopic ultrasound in gastro-oesophageal cancer Systematic review of endoscopic ultrasound in gastro-oesophageal cancer Systematic review of endoscopic ultrasound in gastro-oesophageal cancer Harris KM, Kelly S, Berry E, Hutton J, Roderick P, Cullingworth J, Gathercole L, O'Connor PJ, Boyce JC, Smith MA Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation Harris KM, Kelly S, Berry E, Hutton J, Roderick P, Cullingworth J, Gathercole L, O'Connor PJ, Boyce JC, Smith MA. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. Health Technology Assessment 1998; 2(18): 1-134 Authors' objectives The aim was to review the literature relating tho the use of endoscopic ultrasound for the preoperative staging of gastro-oesophageal cancer, especially regarding staging performance and staging impact

Health Technology Assessment (HTA) Database.1998

8568. Management of lung cancer

Management of lung cancer Management of lung cancer Management of lung cancer NHS Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHS Centre for Reviews and Dissemination. Management of lung cancer. York: Centre for Reviews and Dissemination (CRD) 1998: 12 Authors' objectives This report summarises (...) the research evidence on the management of lung cancer. Authors' conclusions Lung cancer is the third most common cause of death in the UK. The disease progresses rapidly and the prognosis is usually poor; around 80% of patients die within a year of diagnosis. Since cigarette smoking is responsible for about 90% of cases of lung cancer, action against smoking should be the primary focus of efforts to improve outcomes. A range of co-ordinated interventions to reduce smoking should be provided at both local

Health Technology Assessment (HTA) Database.1998

8569. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer

Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer Aronson N, Seidenfeld J, Samson DJ, Albertson PC, Bayoumi AM, Bennett C Record Status This is a bibliographic record (...) of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Aronson N, Seidenfeld J, Samson DJ, Albertson PC, Bayoumi AM, Bennett C. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 4. 1998 Authors' objectives This report

Health Technology Assessment (HTA) Database.1998

8570. Psycho-social interventions in oncology: counselling services for women with breast cancer

Psycho-social interventions in oncology: counselling services for women with breast cancer Psycho-social interventions in oncology: counselling services for women with breast cancer Psycho-social interventions in oncology: counselling services for women with breast cancer Whatley P, Milne R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Whatley P, Milne R. Psycho-social interventions in oncology: counselling services for women with breast cancer. Southampton: Wessex Institute for Health Research and Development (WIHRD) 1998: 20 Authors' objectives To provide an overview of the value of counselling services for women with breast cancer. Authors' conclusions There is good evidence from trials that counselling helps women with breast cancer in terms of psychological adjustment in the months after diagnosis. The Committee noted

Health Technology Assessment (HTA) Database.1998

8571. Irinotecan as second line chemotherapy in colorectal cancer (preliminary report)

Irinotecan as second line chemotherapy in colorectal cancer (preliminary report) Irinotecan as second line chemotherapy in colorectal cancer (preliminary report) Irinotecan as second line chemotherapy in colorectal cancer (preliminary report) Smithies A, Stein K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Smithies A, Stein K (...) . Irinotecan as second line chemotherapy in colorectal cancer (preliminary report) Southampton: Wessex Institute for Health Research and Development (WIHRD) 1998 Authors' objectives To provide an overview of the use of irinotecan as second line chemotherapy in colorectal cancer. Authors' conclusions There is evidence from observational studies that intravenous irinotecan given once every 3 weeks at a dosage of 350mg/m2 to patients with progressive metastatic colorectal cancer unresponsive to 5FU, exerts

Health Technology Assessment (HTA) Database.1998

8572. Cryosurgery for prostate cancer

Cryosurgery for prostate cancer Cryosurgery for prostate cancer Cryosurgery for prostate cancer Alberta Heritage Foundation for Medical Research Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Alberta Heritage Foundation for Medical Research. Cryosurgery for prostate cancer. Edmonton: Alberta Heritage Foundation for Medical Research (...) (AHFMR). Technote TN 16. 1998 Authors' objectives This report has been prepared in response to a request for an update on the status of cryosurgery as a treatment for prostatic cancer, in relation to reimbursement issues. There was interest in whether the procedure is still considered experimental or in the research stage. Authors' conclusions Cryosurgery for prostate cancer is a technology whose efficacy has yet to be established. The only long-term results available were obtained from studies which

Health Technology Assessment (HTA) Database.1998

8573. Evidence-based nursing: radiotherapy for patients with cancer

Evidence-based nursing: radiotherapy for patients with cancer Evidence-based nursing: radiotherapy for patients with cancer Evidence-based nursing: radiotherapy for patients with cancer Forsberg C, Wengstrom Y Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Forsberg C, Wengstrom Y. Evidence-based nursing: radiotherapy for patients (...) with cancer. Stockholm: Swedish Council on Technology Assessment in Health Care (SBU) 1998: 79 Authors' objectives The aim of this systematic literature review is to report on the scientific evidence concerning nursing in radiotherapy. Authors' conclusions Radiotherapy for cancer is often associated with complications and side effects. These, along with the worry and anxiety which the patient may experience from the disease itself and from treatment, place special demands on nursing intervention

Health Technology Assessment (HTA) Database.1998

8574. The management of colorectal cancer

The management of colorectal cancer The management of colorectal cancer The management of colorectal cancer NHS Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHS Centre for Reviews and Dissemination. The management of colorectal cancer. York: University of York. Effective Health Care 3(6). 1998 (...) Authors' objectives To summarise the research evidence which informed the Department of Health's Clinical Outcomes Group's guidance on commissioning cancer services, based on a series of systematic reviews. Authors' conclusions Colorectal (bowel) cancer is the second most common cause of cancer death in the UK. The disease is curable when not too far advanced and UK survival rates could be substantially improved with better management. Project page URL Indexing Status Subject indexing assigned by CRD

Health Technology Assessment (HTA) Database.1998

8575. Screening for ovarian cancer: a systematic review

Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review Bell R, Petticrew M, Luengo S, Sheldon T A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bell R, Petticrew M, Luengo S, Sheldon T A. Screening for ovarian cancer: a systematic review (...) . Health Technology Assessment 1998; 2(2): 1-84 Authors' objectives To evaluate the performance of current screening tests for ovarian cancer. To assess the adverse effects of screening, including morbidity associated with surgical intervention and psychological morbidity associated with false-positive diagnosis. To report on the stage of development of newer methods of screening. To investigate the potential cost-effectiveness of screening in different risk groups. Authors' conclusions Further

Health Technology Assessment (HTA) Database.1998

8577. Systematic review of endoscopic ultrasound in gastro-oesophageal cancer

Systematic review of endoscopic ultrasound in gastro-oesophageal cancer Systematic review of endoscopic ultrasound in gastro-oesophageal cancer Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue

NIHR HTA programme1998

8578. Screening for ovarian cancer: a systematic review

Screening for ovarian cancer: a systematic review Screening for ovarian cancer: a systematic review Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0

NIHR HTA programme1998

8579. Randomised controlled trial of effects of early discharge after surgery for breast cancer.

Randomised controlled trial of effects of early discharge after surgery for breast cancer. 9804712 1998 12 14 1998 12 14 2014 06 17 0959-8138 317 7168 1998 Nov 07 BMJ (Clinical research ed.) BMJ Randomised controlled trial of effects of early discharge after surgery for breast cancer. 1275-9 To determine the effect of early discharge from hospital after surgery for breast cancer on physical and psychological illness. Randomised controlled trial comparing discharge two days after surgery (before (...) removal of drain) with standard management (discharge after removal of drain). Regional breast unit. 100 women with early breast cancer undergoing mastectomy and axillary node clearance (20) or breast conservation surgery (80). Physical illness (infection, seroma formation, shoulder movement) and psychological illness (checklist of concerns, Rotterdam symptom questionnaire, hospital anxiety and depression scale) preoperatively and at one month and three months postoperatively. Women discharged early

BMJ1998 Full Text: Link to full Text with Trip Pro

8580. Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial.

Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial. 9554895 1998 05 21 1998 05 21 2014 06 17 0959-8138 316 7140 1998 Apr 25 BMJ (Clinical research ed.) BMJ Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial. 1267-71 To assess the medical and psychosocial effects of early hospital discharge after surgery for breast cancer on complication rate, patient satisfaction, and psychosocial outcomes (...) . Randomised trial comparing discharge from hospital 4 days after surgery (with drain in situ) with discharge after drain removal (mean 9 days in hospital). Psychosocial measurements performed before surgery and 1 and 4 months after. General hospital and cancer clinic in Rotterdam with a socioeconomically diverse population. 125 women with operable breast cancer. Incidence of complications after surgery for breast cancer, patient satisfaction with treatment, and psychosocial effects of short stay or long

BMJ1998 Full Text: Link to full Text with Trip Pro